Clover Health Investments Corp
NASDAQ:CLOV
Relative Value
The Relative Value of one CLOV stock under the Base Case scenario is 1.9648 USD. Compared to the current market price of 0.6445 USD, Clover Health Investments Corp is Undervalued by 67%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
CLOV Competitors Multiples
Clover Health Investments Corp Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
US |
Clover Health Investments Corp
NASDAQ:CLOV
|
315.2m USD | 0.2 | -1.5 | -0.1 | -0.1 | ||
US |
UnitedHealth Group Inc
NYSE:UNH
|
454.5B USD | 1.2 | 29.6 | 13.4 | 15.1 | ||
US |
Elevance Health Inc
NYSE:ELV
|
122.2B USD | 0.7 | 19.6 | 13.1 | 15.4 | ||
US |
Anthem Inc
NYSE:ANTM
|
116.4B USD | 0.8 | 18.6 | 12.7 | 14.7 | ||
US |
Centene Corp
NYSE:CNC
|
39.9B USD | 0.3 | 14.6 | 8 | 10.8 | ||
US |
Humana Inc
NYSE:HUM
|
38.7B USD | 0.4 | 19.4 | 9 | 11.1 | ||
US |
Molina Healthcare Inc
NYSE:MOH
|
20B USD | 0.6 | 18.7 | 7.5 | 8.3 | ||
US |
Healthequity Inc
NASDAQ:HQY
|
6.9B USD | 6.9 | 123.3 | 26.1 | 57.3 | ||
BR |
Notre Dame Intermedica Participacoes SA
OTC:NTEDY
|
6.4B USD | 3.2 | 45.9 | 19.3 | 23.8 | ||
BR |
Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
|
27.9B BRL | 1 | -37.7 | 10.6 | 33.3 | ||
US |
Progyny Inc
NASDAQ:PGNY
|
3.1B USD | 2.8 | 49.8 | 42.2 | 43.7 |